Compliance Gone Wild (OrthoSpineNews)
While Federal Investigators have the Brinks trucks lined up delivering penalty revenues in the billions, today’s pharmaceutical and medical device companies are forced to take extreme actions to safeguard themselves from scrutiny. No longer is it enough to do things in a compliant manner, in this environment companies find themselves working to prove that they are NOT violating off-label marketing, anti-Kickback, of FCPA guidelines. Proving a negative is almost impossible, so in efforts to thwart personnel from violating these laws companies are implement...
